EMeRGE and the SNAP team are proud to announce the results of the SNAP trial. Paper was published in The Lancet today. Thanks to the hard work of the ED and Toxicology staff showing that a modified 12 hour acetylcysteine regimen resulted in less vomiting, fewer anaphylactoid reactions, and reduced need for treatment interruption.